Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 63,691 | 63,094 | 60,427 | 58,648 | 57,631 |
| Cost of Goods | 10,757 | 9,746 | 9,642 | 9,037 | 9,013 |
| Gross Profit | 52,934 | 53,348 | 50,785 | 49,611 | 48,618 |
| Operating Expenses | 56,602 | 54,983 | 49,413 | 45,937 | 46,793 |
| Operating Income | -2,911 | -889 | 2,014 | 3,711 | 1,838 |
| Interest Expense | 85 | 0 | -87 | 0 | 73 |
| Other Income | 57 | 59 | 37 | 110 | 74 |
| Pre-tax Income | -2,939 | -830 | 2,138 | 3,821 | 1,839 |
| Income Tax | 55 | 53 | 179 | 109 | 38 |
| Net Income Continuous | -2,994 | -883 | 1,959 | 3,712 | 1,801 |
| Net Income | $-2,994 | $-883 | $1,959 | $3,712 | $1,801 |
| EPS Basic Total Ops | -0.10 | -0.03 | 0.06 | 0.12 | 0.06 |
| EPS Basic Continuous Ops | -0.10 | -0.03 | 0.07 | 0.12 | 0.06 |
| EPS Diluted Total Ops | -0.10 | -0.03 | 0.07 | 0.11 | 0.06 |
| EPS Diluted Continuous Ops | -0.10 | -0.03 | 0.06 | 0.11 | 0.06 |
| EBITDA(a) | $-1,308 | $656 | $3,511 | $4,920 | $3,068 |